These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 9456571)

  • 1. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J
    Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postoperative behavior of intraocular pressure after posterior Nd:YAG laser capsulotomy--critical evaluation in preventive administration of local carbonic anhydrase II inhibitor dorzolamide hydrochloride (Trusopt)].
    Lachmann C; Jörg KM; Trinkmann R
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):326-30. PubMed ID: 10048009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical carbonic anhydrase inhibitors: a new perspective in glaucoma therapy.
    Hiett JA; Dockter CA
    Optom Clin; 1992; 2(4):97-112. PubMed ID: 1286242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.
    Nesher R; Ticho U
    Isr Med Assoc J; 2003 Apr; 5(4):260-3. PubMed ID: 14509130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
    Pajic B;
    Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of glaucoma with carbonic anhydrase inhibitors in eyewash: medium term retrospective experience with dorzolamide].
    Detry-Morel M; De Hoste F
    Bull Soc Belge Ophtalmol; 1997; 267():157-66. PubMed ID: 9745826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of dorzolamide as added therapy in glaucoma patients with maximum tolerated drug therapy. A pilot study].
    Denk PO; Knorr M; Kriegerowski M; Thiel HJ
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):360-4. PubMed ID: 9333661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
    Pfeiffer N; Grehn F; Hennekes R; Garus H
    Fortschr Ophthalmol; 1990; 87(2):128-30. PubMed ID: 2192972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial of dorzolamide for glaucoma.
    Gillies WE; Brooks AM
    Ophthalmic Surg Lasers; 1998 Sep; 29(9):728-32. PubMed ID: 9760608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carbonic anhydrase inhibitors with topical action in the treatment of glaucomatous diseases. A preliminary note].
    Gafencu O; Armegioiu M; Ionita M
    Oftalmologia; 1997; 41(1):66-8. PubMed ID: 9138500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF; Maren TH
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma.
    Scardillo A; Pugliese M; De Majo M; Niutta PP; Pugliese A
    Vet Ther; 2010; 11(3):E1-6. PubMed ID: 20960417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical carbonic anhydrase inhibitors.
    Talluto DM; Wyse TB; Krupin T
    Curr Opin Ophthalmol; 1997 Apr; 8(2):2-6. PubMed ID: 10168353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride].
    Egorov AE
    Vestn Oftalmol; 1996; 112(2):3-4. PubMed ID: 9045485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of a topical carbonic anhydrase inhibitor in patients affected by chronic simple glaucoma.
    D'Andrea A; D'Andrea D; Ferreri G
    Acta Ophthalmol Scand Suppl; 1998; (227):36-8. PubMed ID: 9972339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma.
    Portellos M; Buckley EG; Freedman SF
    J AAPOS; 1998 Feb; 2(1):43-7. PubMed ID: 10532366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dorzolamide-timolol combination versus concomitant administration of its components.
    Odberg T
    Ophthalmology; 1999 Jun; 106(6):1044-5. PubMed ID: 10366067
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.